Monoclonal Antibody With or Without gp100 Peptides Plus Montanide ISA-51 in Treating Patients With Stage IV Melanoma

This study has been completed.

Study NCT00077532 Information provided by National Cancer Institute (NCI)

First Received: February 10, 2004 Last Updated: March 10, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	January 2008 (Final data collection date for primary outcome measure)